Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 277,000 | 123,000 | 139,000 | 146,000 | 168,000 |
| Receivables | 1,796,000 | 1,712,000 | 1,621,000 | 1,608,000 | 1,580,000 |
| Inventories | 1,566,000 | 1,300,000 | 1,228,000 | 1,166,000 | 1,134,000 |
| Other current assets | 1,019,000 | 3,024,000 | 3,083,000 | 922,000 | 1,046,000 |
| TOTAL | $4,847,000 | $6,334,000 | $6,234,000 | $4,003,000 | $3,971,000 |
| Non-Current Assets | |||||
| PPE Net | 1,942,000 | 1,820,000 | 1,782,000 | 1,782,000 | 1,730,000 |
| Intangibles | 18,089,000 | 14,937,000 | 14,627,000 | 14,283,000 | 13,885,000 |
| Other Non-Current Assets | 1,879,000 | 1,217,000 | 1,158,000 | 932,000 | 794,000 |
| TOTAL | $21,910,000 | $17,974,000 | $17,567,000 | $16,997,000 | $16,409,000 |
| Total Assets | $26,756,000 | $24,309,000 | $23,802,000 | $20,999,000 | $20,379,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,297,000 | 1,949,000 | 1,638,000 | N/A | 1,820,000 |
| Accounts payable and accrued liabilities | 512,000 | 524,000 | 498,000 | 349,000 | 453,000 |
| Accrued Expenses | 1,932,000 | 1,932,000 | 1,963,000 | 2,246,000 | 2,469,000 |
| Other current liabilities | 513,000 | 445,000 | 380,000 | 412,000 | 340,000 |
| TOTAL | $4,254,000 | $4,850,000 | $4,479,000 | $5,260,000 | $5,082,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 9,590,000 | 7,591,000 | 7,590,000 | 4,803,000 | 4,806,000 |
| Other Non-Current Liabilities | 2,406,000 | 2,027,000 | 2,059,000 | 1,882,000 | 1,774,000 |
| TOTAL | $12,803,000 | $10,034,000 | $10,090,000 | $7,013,000 | $7,008,000 |
| Total Liabilities | $17,057,000 | $14,884,000 | $14,569,000 | $12,273,000 | $12,090,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,393,824 | 1,392,973 | 1,390,653 | 1,385,962 | 1,383,801 |
| Common Shares | 16,000 | 16,000 | 16,000 | 16,000 | 16,000 |
| Retained earnings | -6,249,000 | -6,375,000 | -6,528,000 | -6,953,000 | -7,339,000 |
| Other shareholders' equity | 139,000 | 79,000 | 88,000 | 34,000 | 25,000 |
| TOTAL | $9,699,000 | $9,425,000 | $9,233,000 | $8,726,000 | $8,289,000 |
| Total Liabilities And Equity | $26,756,000 | $24,309,000 | $23,802,000 | $20,999,000 | $20,379,000 |